37 suspended. 37 Phase 2, 7 Phase 1, 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 37 | Suspended 37 |
| Phase 1 | 7 | Suspended 7 |
| Phase 3 | 6 | Suspended 6 |
Follow Urogenital Diseases: new trials by email Literature Review of Urogenital Diseases trials Research Report on Urogenital Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Modified Autologous Leukocyte Cells for the Treatment of Acute Kidney Injury After Cardiac Surgery Placebo, M2RLAB 001 - Acute Kidney Injury | Phase 2 | Suspended | M2RLAB SL | 98 | 2025-12-14 | 2026-09-21 |
| Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer Abivertinib, Abiraterone - Prostate Cancer, Prostate Cancer Metastatic | Phase 2 | Suspended | Sorrento Therapeutics, Inc. | 100 | 2025-09-01 | 2024-03-18 |
| Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC Pembrolizumab, Axitinib - Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma | Phase 2 | Suspended | H. Lee Moffitt Cancer Center and Research Institute | 75 | 2025-02-25 | 2026-03-06 |
| Elimination of Prostate Cancer Treatment Side Effects Using a Nutraceutical N-111, Placebo - Prostate Cancer | Phase 1 / Phase 2 | Suspended | Optimal Health Research | 100 | 2024-08-15 | 2025-03-11 |
| Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer Biospecimen Collection, Bone Scan, Clinical Observation - Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 | Suspended | Mayo Clinic | 236 | 2024-05-03 | 2026-08-20 |
| Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC 177Lu girentuximab, Nivolumab, Cabozantinib - Advanced Cancer, Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | Suspended | M.D. Anderson Cancer Center | 100 | 2023-06-30 | 2026-10-08 |
| Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer VLP-encapsulated TLR9 Agonist CMP-001,, Nivolumab - Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 | Phase 2 | Suspended | Emory University | 10 | 2023-06-07 | 2026-10-13 |
| Rescue Progesterone Supplementation During Frozen Embryo Transfer Progesterone Effervescent Vaginal Tablet - Fertility Issues, Embryo Implantation | Phase 2 | Suspended | Clinique Ovo | 150 | 2022-12-01 | 2025-12-09 |
| A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers XmAb20717 - Microsatellite High Cancers, Peritoneal Mesothelioma | Phase 2 | Suspended | M.D. Anderson Cancer Center | 140 | 2022-08-05 | 2026-10-13 |
| Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation Anakinra 100Mg/0.67Ml Inj Syringe, Prednisone, Placebo of Prednisone - Gout, Chronic Kidney Disease | Phase 2 | Suspended | Assistance Publique - Hôpitaux de Paris | 204 | 2022-06-02 | 2026-02-04 |
| White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA Clinical Observation, Patient Observation, Questionnaire Administration - Prostate Adenocarcinoma, PSA Failure | Phase 2 | Suspended | City of Hope Medical Center | 133 | 2021-05-10 | 2026-08-10 |
| Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer Hypofractionated Radiation, Clinical Follow-Up and Assessments - Endometrial Cancer | Phase 1 / Phase 2 | Suspended | University of Chicago | 100 | 2021-01-15 | 2026-09-10 |
| Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer Hyperpolarized C13, Magnetic Resonance Imaging (MRI) - Prostate Cancer, Advanced Prostate Carcinoma | Phase 2 | Suspended | Ivan de Kouchkovsky, MD | 75 | 2020-07-16 | 2026-06-23 |
| The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy aspirin enteric coated tablet 75 mg - Hiv, Cardiovascular Diseases | Phase 2 | Suspended | Muhimbili University of Health and Allied Sciences | 454 | 2020-03-02 | 2022-09-01 |
| A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor Lucitanib, Nivolumab - Advanced Solid Tumor, Gynecologic Cancer | Phase 1 / Phase 2 | Suspended | Clovis Oncology, Inc. | 227 | 2019-07-29 | 2022-12-20 |
| Efficacy and Safety of Immunoglobulin Associated With Rituximab Versus Rituximab Alone in Childhood-Onset Steroid-dependent Nephrotic Syndrome immunoglobulin IV - Steroid-Dependent Nephrotic Syndrome | Phase 2 / Phase 3 | Suspended | Assistance Publique - Hôpitaux de Paris | 90 | 2019-04-03 | 2021-10-04 |
| Montelukast for Prevention & Treatment of OHSS dydrgesterone 10 mg( tab)/12hs/14 days, montelukast 10 mg(tab) oral/24hs/ 7 days dydrgesterone 10 mg( tab) oral/12hs/14 days - Ovarian Hyperstimulation Syndrome | Phase 2 | Suspended | Benha University | 20 | 2018-12-05 | 2022-09-21 |
| The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency hucMSCs - Premature Ovarian Failure | Phase 2 | Suspended | Sclnow Biotechnology Co., Ltd. | 12 | 2018-10-01 | 2026-04-23 |
| Efficacy of Aspirin and L-arginine in High Risk Preeclamptic L-arginine, Placebo (for L-arginine), acetylsalicylic acid - High Risk Pregnancy | Phase 2 | Suspended | University of Guadalajara | 82 | 2018-07-01 | 2020-11-27 |
| Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma Biopsy, Biospecimen Collection, Computed Tomography - Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 | Phase 2 | Suspended | M.D. Anderson Cancer Center | 123 | 2018-06-14 | 2026-10-06 |
Showing 20 of 37. Sign in to see all of them.
Prostatic Neoplasms (7) · Carcinoma, Renal Cell (5) · HIV Infections (5) · Renal Insufficiency, Chronic (3) · Endometrial Neoplasms (2) · Infertility (2) · Uterine Cervical Neoplasms (2) · Abortion, Spontaneous (1) · Acquired Immunodeficiency Syndrome (1) · Acute Kidney Injury (1) · Breast Neoplasms (1) · Carcinoma, Neuroendocrine (1) · Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Diabetic Nephropathies (1)
Female Urogenital Diseases and Pregnancy Complications (23) · Genital Diseases (23) · Female Urogenital Diseases (20) · Male Urogenital Diseases (20) · Neoplasms (16) · Neoplasms by Site (16) · Urogenital Neoplasms (15) · Urologic Diseases (12) · Kidney Diseases (11) · Genital Diseases, Female (8) · Genital Diseases, Male (8) · Genital Neoplasms, Male (7) · Immune System Diseases (7) · Infections (7)
Magnetic Resonance Spectroscopy (3) · Nivolumab (3) · Nelfinavir (2) · Observation (2) · Specimen Handling (2) · Watchful Waiting (2) · capravirine (2) · lamivudine, zidovudine drug combination (2) · 68Ga-DKFZ-PSMA-11 (1) · Arginine (1) · Aspirin (1) · Axitinib (1) · Biopsy (1) · CYT003-QbG10 (1) · Cefoperazone (1)
Assistance Publique - Hôpitaux de Paris (3) · M.D. Anderson Cancer Center (3) · Agouron Pharmaceuticals (2) · Mayo Clinic (2) · AstraZeneca (1) · Azidus Brasil (1) · Benha University (1) · City of Hope Medical Center (1) · Clinique Ovo (1) · Clovis Oncology, Inc. (1) · Emory University (1) · Fundación Santa Fe de Bogota (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Homerton University Hospital NHS Foundation Trust (1)
United States (20) · France (4) · Spain (3) · Belgium (2) · Canada (2) · China (2) · Dominican Republic (2) · Italy (2) · Austria (1) · Brazil (1) · Colombia (1) · Egypt (1) · Germany (1) · Mexico (1) · Puerto Rico (1)
Alan Jeppsen, MD (1) · Arvind Nageshwara Dasaru, MD (1) · Chad Tang (1) · Christina Son, MD (1) · Clayton S Lau (1) · Eligius F Lyamuya, MD, MMed, PhD, FTAAS, FCPath (1) · Eric Jonasch, MD (1) · Erika Hamilton, MD (1) · Felipe Garcia, MD, PhD (1) · Guangzhi Liu, Dr (1) · Hang-Korng EA, PhD-MD (1) · Hyman Muss, MD (1) · Ivan de Kouchkovsky, MD (1)
PMID 18653184, PMID 21317433, PMID 22065264, PMID 22611117, PMID 23258386, PMID 32967877, PMID 34717797, PMID 36456193, PMID 39390760, PMID 39513526, PMID 40152935, PMID 40880360, PMID 40915303, PMID 42719952
2017 (1), 2023 (1), D43TW009775 (1), P30CA016672 (1), P30CA033572 (1), R01CA215694 (1), R25TW011227 (1), U01EB026412 (1)